I may be provocative however, it is to call out malfeasance by the current managements ability to do their job properly.
People on this board post inaccurate statements and garbage, I correct inaccuracies.
I never instigate name calling but, I do reply to people who do and with an equal response.
Got to start the food preparations, have a Happy Thanksgiving
Remember tox told you to buy at $1.25 back in late August, zacks called the buy at $1.70
Short interest means nothing with BLRX, too many cheap warrants available
Lost of upcoming investor conferences means they need to find new money. Time by the CEO would be better spent finding new candidates, better oversight of current clinical trials
Don't you wish you listened to tox?
Happy Thanksgiving......... Turkey
I will let you in on a little info, the only entities shorting and can move the needle downward are the same major investors that own shares. With the lack of liquidity, large sell orders or buy orders can cause an imbalance, the broker dealers AKA market makers buy or sell from their account to balance the orders. As of late the imbalance of sell orders allows the broker dealers to low ball the ask, investors hedging keep selling, artificially lowering the share price.
No options so, the only way to hedge is to short against your long position. What you say? Own and short shares? That makes no sense?
But it does if you were a large investor that was part of the add on offerings. Not only did the investors get cheap shares they also received warrants, most of the series 2 warrants have a exercise price of $1.75
So Readers Digest version, major investors part of the add on offerings holding series 2 warrants can short the #$%$ out of BLRX without any fear of causing a short squeeze. If the share price ran to $2.00 tomorrow, the investors would simply exercise the warrant to purchase shares at $1.75 to replace the borrowed (short) shares
That's tonight lesson, bring the teacher an apple tomorrow.
for most if not all of you, the BLRX longs. You are unhappy because you paid to much to own a piece of BLRX
The good news is that I have purchased a few shares at $1.25 and again at $1.21
Rest easy knowing management will hook up with a few #$%$ balls and talk them into purchasing shares for an add on offering at a 20% discount but, not before they pump the share price up to the $3.70 range
All should happen starting by mid December and with a big pop in February 2016
In the mean time, keep the heat on the CEO to do her job with a little more vigor
Other reporting websites contain errors and are only as accurate as the person doing the reporting.
All other institutions you have provided have also reduced their positions in BLRX
Novartis has not provided their 13F or G filing for this year. They probably did not need any lunch money, So I am assuming they did not sell any shares of BLRX?
Some large entity must have insight to the open label studies and is selling at every opportunity. Management is helping with fluff PR's. Everyone knew that when the BL1040 trial failed to meet the primary and secondary endpoints, it would hurt the share price much more than the CEO had anticipated and more than the initial sell off.
Roths $10.00 price target was slashed and major investors no longer had any confidence in the CEO
End of September 2015
Morningstar and others are still showing Broadfin holding over 3 Mil shares as of 9/30/15
If you google Broadfin Capital, LLC 13F holdings on page 4 you will see they sold out of BLRX
Investors selling, no faith in the CEO or managements ability to produce a successful trial to get a candidate to market
$1.21 Looks like the bottom, give or take a few pennies.
Oh boy, another rat study
Gilly must be desperate for cash, look for another add on offering at a 20% discount to the market close
I told you the s/p would go to $1.25 and I told you to buy at $1.25, may go as low as 1.21, can't time the market perfectly
We go higher rolling into middle of January 2016, for now we are in the dumper, no pun intended
Tee hee hee
1 ID tox, I don't have a Twitter account
If you were not a moron you would be able to figure that out
Right....... I tell you back in late August we are headed for $1.25 when the s/p was $1.79 and I don't know what I am talking about
Let me guess, you were in the 14 year program to finish high school
Small buys to drive the share price up then much bigger sells driving the share price down. Someone's keeping the share price artificially higher to help their pals sell out of their positions.
$1.21 Looks to be the bottom - Can't understand why all the selling especially after the positive results just announced for BL8040. Open label gives a very good insight as how the patients are responding. I believe the biggest part of the trial yet to be announced is do the patient say in remission? Maybe this is the issue for the selling that remission is not lasting longer than the average two years, which is the present average for AML patients.
If only that was your biggest concern, you should be every happy. Gilly took your hard earned money and investment and turned it into lunch money at McDonald's.
At this rate, you and athersyss are never getting out of moms basement.
Ahhhhhh, I see my sentiment is gaining traction. I'm not a basher just a realist.............We need a new CEO, one that has a clue how to run a business. Add to that, I am not too impressed with her skills as a medical professional.
Who was over looking BPLH conducting the "slam dunk" trial for BL1040 or BCM?
Our CEO is asleep at the wheel and don't think for a moment Novartis isn't aware of this issue!
To short at this level is a no no
Way to many shares long right now to call it quits
I figure if I #$%$ enough, management will get ther #$%$ together and move some trials along and provide investors with a little insight, win or lose ?